In one paragraphArticle in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Shuanghui HuaCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, BK21 FOUR KNU Community-Based Intelligent Novel Drug Discovery Educa-tion Unit 80 Daehak-ro, Buk-gu Daegu 41566 Korea tlee@knu.ac.kr.ORCID https://orcid.org/0009-0001-2079-4608 Jimin MoonCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, BK21 FOUR KNU Community-Based Intelligent Novel Drug Discovery Educa-tion Unit 80 Daehak-ro, Buk-gu Daegu 41566 Korea tlee@knu.ac.kr.ORCID https://orcid.org/0009-0006-6241-6396 Hyojin LeeCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, BK21 FOUR KNU Community-Based Intelligent Novel Drug Discovery Educa-tion Unit 80 Daehak-ro, Buk-gu Daegu 41566 Korea tlee@knu.ac.kr.ORCID https://orcid.org/0009-0003-6077-4534 Jungtae KimCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, BK21 FOUR KNU Community-Based Intelligent Novel Drug Discovery Educa-tion Unit 80 Daehak-ro, Buk-gu Daegu 41566 Korea tlee@knu.ac.kr.ORCID https://orcid.org/0009-0001-3550-2188 Geonho YoonCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, BK21 FOUR KNU Community-Based Intelligent Novel Drug Discovery Educa-tion Unit 80 Daehak-ro, Buk-gu Daegu 41566 Korea tlee@knu.ac.kr.ORCID https://orcid.org/0009-0008-7397-9850 Dong Jae BaekCollege of Pharmacy, Natural Medicine Research Institute, Mokpo National University Jeonnam 58554 South Korea dbaek@mokpo.ac.kr.
Taeho LeeCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, BK21 FOUR KNU Community-Based Intelligent Novel Drug Discovery Educa-tion Unit 80 Daehak-ro, Buk-gu Daegu 41566 Korea tlee@knu.ac.kr.ORCID https://orcid.org/0000-0002-4791-1907 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
A traceless and efficient solid-phase synthetic strategy was developed for the construction of thiazolo[4,5-
Identifiers
PMID41103939
PMCPMC12522109
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390